Barclays raised the firm’s price target on Quest Diagnostics (DGX) to $185 from $175 and keeps an Equal Weight rating on the shares. The company’s “strong” Q1 reinforces Quest “as a ...

A recently published study has identified collagen type X α 1 chain (CoL10A1) as a promising target for treating brain metastasis in breast cancer patients. The research, conducted by a team at First ...

May 13, 2025 — Astronomers have developed a groundbreaking computer simulation to explore, in unprecedented detail, magnetism and turbulence in the interstellar medium (ISM) -- the vast ocean of ...

Additionally, BCB-276 keeps the blood-brain barrier intact and minimizes any on-target, off-tumor toxicities. The phase 1 BrainChild-03 is enrolling patients between the ages of 1 and 26 years with ...

November 25, 2024 • Books We Love returns with 350+ new titles handpicked by NPR staff and trusted critics. Find 12 years of recommendations all in one place — that's nearly 4,000 great reads ...

We’re sorry, this feature is currently unavailable. We’re working to restore it. Please try again later.